One in 13 U.S. Adults Report Long COVID Symptoms
THURSDAY, July 7, 2022 (HealthDay News) -- One in five U.S. adults (19 percent) who report having had COVID-19 say they have long COVID symptoms, according to a report from the U.S. Centers for Disease Control and Prevention National Center for Health Statistics.
Beginning June 1, the Household Pulse Survey, administered in partnership between the U.S. Census Bureau and the National Center for Health Statistics, began asking questions to assess the prevalence of post-COVID-19 conditions. Data were collected from June 1 to June 13, 2022.
The newly collected data show that one in 13 U.S. adults overall (7.5 percent) have long COVID symptoms, defined as symptoms not present prior to COVID-19 infection and lasting three or more months after first contracting the virus. Long COVID is less likely among older adults than younger adults, with nearly three times as many adults ages 50 to 59 years reporting long COVID than those aged 80 years or older. Long COVID is more likely among women than men (9.4 versus 5.5 percent), and it is highest among Hispanic adults (9 percent) versus non-Hispanic White (7.5 percent) or Black (6.8 percent) adults.
There is geographic variance in the prevalence of long COVID symptoms. Prevalence is highest in Kentucky (12.7 percent), Alabama (12.1 percent), and Tennessee and South Dakota (11.6 percent) and lowest in Hawaii (4.5 percent), Maryland (4.7 percent), and Virginia (5.1 percent).
Related Posts
Pediatric Cannabis Poisoning Increased With Edible Cannabis Sales
WEDNESDAY, Jan. 18, 2023 (HealthDay News) -- Following cannabis legalization in...
More Than 10 Million People Died of Cancer Worldwide in 2019
TUESDAY, Jan. 4, 2022 (HealthDay News) -- Cancer remains a major killer, with 10...
La segregación escolar se vincula con problemas de alcohol entre los jóvenes negros
LUNES, 18 de abril de 2022 (HealthDay News) -- La segregación escolar podría...
Moderna pedirá a la FDA que apruebe su vacuna contra la COVID para los niños pequeños
MIÉRCOLES, 23 de marzo de 2022 (HealthDay News) -- Moderna anunció el miércoles...